Correlation between human immunodeficiency virus type 1 (HIV-1) RNA measurements obtained with dried blood spots and those obtained with plasma by use of Nuclisens EasyQ HIV-1 and Abbott RealTime HIV load tests

Journal of Clinical Microbiology

Volumn 47, Issue 4, 2009, Pages 1031-1036

  Garrido, Carolina ^a   Zahonero, Natalia ^a   Corral, Angélica ^a   Arredondo, Miguel ^a   Soriano, Vincent ^a   De Mendoza, Carmen ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA;

ARTICLE; ASSAY; BLOOD SAMPLING; CLINICAL LABORATORY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; NONHUMAN; PLASMA; PRIORITY JOURNAL; VIREMIA; VIRUS DETECTION; VIRUS LOAD; ANALYTICAL EQUIPMENT; BLOOD; COMPARATIVE STUDY; DESICCATION; DIAGNOSTIC PROCEDURE; EVALUATION; GENETICS; ISOLATION AND PURIFICATION; LABORATORY DIAGNOSIS; METHODOLOGY; SENSITIVITY AND SPECIFICITY; VIROLOGY;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

BLOOD; DESICCATION; HIV-1; HUMANS; MOLECULAR DIAGNOSTIC TECHNIQUES; PLASMA; REAGENT KITS, DIAGNOSTIC; RNA, VIRAL; SENSITIVITY AND SPECIFICITY; SPECIMEN HANDLING; VIRAL LOAD;

EID: 65249161630     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.02099-08     Document Type: Article

References (37)

1. Alvarez-Muñoz, M. T., S. Zaragoza-Rodriguez, O. Rojas-Montes, G. Palacios-Saucedo, G. Vazquez-Rosales, A. Gomez-Delgado, J. Torres, and O. Muñoz. 2005. High correlation of human immunodeficiency virus type-1 viral load measured in dried blood spot samples and in plasma under different storage conditions. Arch. Med. Res. 36:382-386.
2. Amellal, B., C. Katlama, and V. Calvez. 2007. Evaluation of the use of dried spots and of different storage conditions of plasma for HIV-1 RNA quantification. HIV Med. 8:396-400.
3. Ayele, W., R. Schuurman, T. Messele, W. Dorigo-Zetsma, Y. Mengistu, J. Goudsmit, W. Paxton, M. P. de Baar, and G. Pollakis. 2007. Use of dried spots of whole blood, plasma, and mother's milk collected on filter paper for measurement of human immunodeficiency virus type 1 burden. J. Clin. Microbiol. 45:891-896.
4. Barth, R. E., A. M. Wensing, H. A. Tempelman, R. Moraba, R. Schuurman, and A. I. Hoepelman. 2008. Rapid accumulation of nonnucleoside reverse transcriptase inhibitor-associated resistance: evidence of transmitted resistance in rural South Africa. AIDS 22:2210-2212.
5. Bertagnolio, S., L. Soto-Ramirez, R. Pilon, R. Rodriguez, M. Viveros, L. Fuentes, P. R. Harrigan, T. Mo, D. Sutherland, and P. Sandstrom. 2007. HIV-1 drug resistance surveillance using dried whole blood spots. Antivir. Ther. 12:107-113.
6. Bland, J., and D. Altman. 1986. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet i:307-310.
7. Boom, R., C. J. Sol, M. Salimans, C. Jansen, P. Wertheim-van Dillen, and J. van der Noordaa. 1990. Rapid and simple method for purification of nucleic acids. J. Clin. Microbiol. 28:495-503.
8. Brambilla, D., C. Jennings, G. Aldrovandi, J. Bremer, A. Comeau, S. Cassol, R. Dickover, J. Jackson, J. Pitt, J. Sullivan, A. Butcher, L. Grosso, P. Reichelderfer, and S. Fiscus. 2003. Multicenter evaluation of use of dried blood and plasma spot specimens in quantitative assays for human immunodeficiency virus RNA: measurement, precision, and RNA stability. J. Clin. Microbiol. 41:1888-1893.
9. Calmy, A., N. Ford, B. Hirschel, S. J. Reynolds, L. Lynen, E. Goemaere, F. Garcia de la Vega, L. Perrin, and W. Rodriguez. 2007. HIV viral load monitoring in resource-limited regions: optional or necessary? Clin. Infect. Dis. 44:128-134.
10. Cassol, S., N. Lapointe, T. Salas, C. Hankins, M. Arella, M. Fauvel, G. Delage, M. Boucher, J. Samson, and J. Charest. 1992. Diagnosis of vertical HIV-1 transmission using the polymerase chain reaction and dried blood spot specimens. J. Acquir. Immune Defic. Syndr. 5:113-119.
11. Cassol, S., M. J. Gill, R. Pilon, M. Cormier, R. Voigt, B. Willoughby, and J. Forbes. 1997. Quantification of human immunodeficiency virus type 1 RNA from dried plasma spots collected on filter paper. J. Clin. Microbiol. 35: 2795-2801.
12. De Mendoza, C., M. Koppelman, B. Montes, V. Ferre, V. Soriano, H. Cuypers, M. Segondy, and T. Oosterlaken. 2005. Multicenter evaluation of the NucliSens EasyQ HIV-1 v1.1 assay for the quantitative detection of HIV-1 RNA in plasma. J. Virol. Methods 127:54-59.
13. Garcia-Diaz, A., G. Clewley, C. L. Booth, W. Labett, N. McAllister, and A. M. Geretti. 2006. Comparative evaluation of the performance of the Abbott real-time human immunodeficiency virus type 1 (HIV-1) assay for measurement of HIV-1 plasma viral load following automated specimen preparation. J. Clin. Microbiol. 44:1788-1791.
14. Gomes, P., A. Palma, J. Cabanas, A. Abecasis, A. Carvalho, R. Ziermann, I. Diogo, F. Gonçalves, C. Lobo, and R. Camacho. 2006. Comparison of the COBAS TAQMAN HIV-1 HPS with VERSANT HIV-1 RNA 3.0 assay (bDNA) for plasma RNA quantitation in different HIV-1 subtypes. J. Virol. Methods 135:223-228.
15. Hallack, R., L. Doherty, J. Wethers, and M. Parker. 2008. Evaluation of dried blood spots specimens for HIV-1 drug resistance testing using the Trugene HIV-1 genotyping assay. J. Clin. Virol. 41:283-287.
16. Hammer, S., J. Eron, P. Reiss, R. Schooley, M. Thompson, S. Walmsley, P. Cahn, M. A. Fischl, J. M. Gatell, M. S. Hirsch, D. M. Jacobsen, J. S. Montaner, D. D. Richman, P. G. Yeni, and P. A. Volberding. 2008. Antiretroviral treatment of adult HIV infection. 2008 recommendations of the International AIDS Society-USA Panel. JAMA 300:555-570.
17. Koal, T., H. Burhenne, R. Römling, M. Svoboda, K. Resch, and V. Kaever. 2005. Quantification of antiretroviral drugs in dried blood spot samples by means of liquid chromatography/tandem mass spectrometry. Rapid Commun. Mass Spectrom. 19:2995-3001.
18. Lakshmi, V., T. Sudha, M. Bhanurekha, and L. Dandona. 2007. Evaluation of the Murex HIV Ag/Ab Combination assay when used with dried blood spots. Clin. Microbiol. Infect. 13:1134-1136.
19. 18a. Marconi, A., M. Balestrieri, G. Comastri, F. Pulvirenti, W. Gennari, S. Tagliazucchi, M. Pecorari, V. Borghi, D. Marri, and M. Zazzi. 2009. Evaluation of the Abbott Real-Time HIV-1 quantitative assay with dried blood spot specimens. Clin. Microbiol. Infect. 15:93-97.
20. Masciotra, S., C. Garrido, A. Youngpairoj, A. McNulty, N. Zahonero, A. Corral, W. Heneine, C. de Mendoza, and J. García-Lerma. 2007. High concordance between HIV-1 drug resistance genotypes generated from plasma and dried blood spots in antiretroviral-experienced patients. AIDS 21:2503-2511.
21. Mee, P., K. Fielding, S. Charalambous, G. Churchyard, and A. Grant. 2008. Evaluation of the WHO criteria for antiretroviral treatment failure among adults in South Africa. AIDS 22:1971-1977.
22. Murri, R., A. C. Lepri, P. Cicconi, A. Poggio, M. Arlotti, G. Tositti, D. Santoro, M. L. Soranzo, G. Rizzardini, V. Colangeli, M. Montroni, A. D. Monforte, and the ICoNA Study Group. 2006. Is moderate HIV viremia associated with a higher risk of clinical progression in HIV-infected people treated with highly active antiretroviral therapy: evidence from the Italian cohort of antiretroviral-naive patients study. J. Acquir. Immune Defic. Syndr. 41:23-30.
23. Mwaba, P., S. Cassol, A. Nunn, R. Pilon, C. Chintu, M. Janes, and A. Zumla. 2003. Whole blood versus plasma spots for measurement of HIV-1 viral load in HIV-infected African patients. Lancet 362:2067-2068.
24. Mwaba, P., S. Cassol, R. Pilon, C. Chintu, M. Janes, A. Nunn, and A. Zumla. 2003. Use of dried whole blood spots to measure CD4+ lymphocyte counts in HIV-1-infected patients. Lancet 362:1459-1460.
25. Oliver, A., S. Pereira, and D. Clark. 2007. Comparative evaluation of the automated Roche TaqMan real-time quantitative human immunodeficiency virus type 1 RNA PCR assay and the Roche AMPLICOR version 1.5 conventional PCR assay. J. Clin. Microbiol. 45:3616-3619.
26. O'Shea, S., J. Mullen, K. Corbett, I. Chrystie, M. L. Newell, and J. Banatvala. 1999. Use of dried whole blood spots for quantification of HIV-1 RNA. AIDS 13:630-631.
27. Petersen, M. L., M. J. van der Laan, S. Napravnik, J. J. Eron, R. D. Moore, and S. G. Deeks. 2008. Long-term consequences of the delay between virologic failure of highly active antiretroviral therapy and regimen modification. AIDS 22:2097-2106.
28. Sarge-Njie, R., M. Schim Van Der Loeff, S. Ceesay, D. Cubitt, S. Sabally, T. Corrah, and H. Whittle. 2006. Evaluation of the dried blood spot filter paper technology and five testing strategies of HIV-1 and HIV-2 infections in West Africa. Scand. J. Infect. Dis. 38:1050-1056.
29. Steegen, K., S. Luchters, E. Demecheleer, K. Dauwe, K. Mandaliya, W. Jaoko, J. Plum, M. Temmerman, and C. Verhofstede. 2007. Feasibility of detecting HIV-1 drug resistance in DNA extracted from whole blood or dried blood spots. J. Clin. Microbiol. 45:3342-3351.
30. Swanson, P., C. de Mendoza, Y. Joshi, A. Golden, R. Hodinka, V. Soriano, S. Devare, and J. Hackett. 2005. Impact of human immunodeficiency virus type 1 (HIV-1) genetic diversity on performance of four commercial viral load assays: LCx HIV RNA Quantitative, AMPLICOR HIV-1 MONITOR v1.5, VERSANT HIV-1 RNA 3.0, and NucliSens HIV-1 QT. J. Clin. Microbiol. 43:3860-3868.
31. Swanson, P., V. Holzmayer, S. Huang, P. Hay, A. Adebiyi, P. Rice, K. Abravaya, S. Thamm, S. Devare, and J. Hackett. 2006. Performance of the automated Abbott Real Time HIV-1 assay on a genetically diverse panel of specimens from London: comparison to VERSANT HIV-1 RNA 3.0, AMPLICOR HIV-1 MONITOR v1.5, and LCx HIV RNA quantitative assays. J. Virol. Methods 137:184-192.
32. Taylor, B., M. Sobieszczyk, F. McCutchan, and S. Hammer. 2008. The challenge of HIV-1 subtype diversity. N. Engl. J. Med. 358:1590-1602.
33. Toure-Kane, C., H. Ndiaye, S. Diallo, I. Ndiaye, A. Wade, P. Diaw, A. Gaye-Diallo, and S. Mboup. 2008. Quantitation of HIV-1 RNA in dried blood spots by the real-time Nuclisens EasyQ HIV-1 assay in Senegal. J. Virol. Methods 148:291-295.
34. United Nations General Assembly. 2006. Political declaration on HIV/AIDS. United Nations General Assembly document 60/262. United Nations, New York, NY. http://www.unaids.org/en/AboutUNAIDS/Goals/UNGASS.
35. Uttayamakul, S., S. Likanonsakul, R. Sunthornkachit, K. Kuntiranont, S. Louisirirotchanakul, A. Chaovavanich, V. Thiamchai, S. Tanprasertsuk, and R. Sutthent. 2005. Usage of dried blood spots for molecular diagnosis and monitoring HIV-1 infection. J. Virol. Methods 128:128-134.
36. World Health Organization. 2008. Towards Universal Access. Scaling up priority HIV/AIDS interventions in the health sector. Progress report June 2008. World Health Organization, Geneva, Switzerland. http://www.who.int /hiv/pub/2008progressreport/en/index.html.
37. World Health Organization. 2006. Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach. 2006 revision. World Health Organization, Geneva, Switzerland. http://www.who.int/hiv/pub/guidelines/adult/en/index.html.